Search results
Author(s):
Naima Maqsood
,
Christian Ruff
Added:
1 year ago
AHA 23 - Dr Naima Maqsood, CardioNerds ambassador (Temple University Hospital, US) interviews Dr Christian Ruff (Brigham and Women's Hospital, US) on the late-breaking findings from the AZALEA-TIMI 71 randomized trial (Anthos Theraputics, Inc).AZALEA-TIMI 71 aimed to evaluate the bleeding profile of abelacimab as compared to rivaroxaban in patients with atrial fibrillation who are at moderate to…
View more
Author(s):
Madelyn Hurwitz
,
Olayinka J Agboola
,
Abhishek Gami
,
et al
Added:
2 weeks ago
Added:
1 year ago
Source:
AHA
AUTHOR: Jordan RanceThe American Heart Association has announced eight late-breaking science sessions to be presented in Philadelphia from November 10th to November 13th. AHA is focussed on innovation in cardiovascular disease for scientists, clinicians, researchers and other healthcare professionals.Among the event’s highlights are eight late-breaking trial sessions, as listed below.Watch our…
View more
Gender Disparities in PAD
Author(s):
Andrea Martinez
,
Jingwen Huang
,
Arash Harzand
Added:
1 year ago
Article